射频消融后良性甲状腺结节的ACR - TI-RADS风险评分升高。

Tess J Battiola, Richard H Wiggins, Devaprabu Abraham
{"title":"射频消融后良性甲状腺结节的ACR - TI-RADS风险评分升高。","authors":"Tess J Battiola, Richard H Wiggins, Devaprabu Abraham","doi":"10.3174/ajnr.A9028","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Radiofrequency ablation (RFA) has emerged as an effective non-surgical treatment for symptomatic benign thyroid nodules and toxic adenomas. While post-RFA ultrasonographic changes are expected, they may inadvertently evoke alarm and prompt unnecessary interventions when risk stratification models such as the American College of Radiology Thyroid Imaging Reporting & Data System (ACR TI-RADS) are applied. This study aims to quantify the ultrasound imaging changes using TIRADS scoring of thyroid nodules before and after RFA, and we highlight that these changes should not be used as a basis for clinical action.</p><p><strong>Materials and methods: </strong>This retrospective study analyzed patients who underwent RFA for symptomatic thyroid nodules at a quaternary care academic medical center between May 2021 and May 2024. All nodules were assessed using the ACR TI-RADS calculator and underwent fine-needle aspiration (FNA) biopsy prior to treatment. Following RFA, ultrasonography was conducted at 3-month intervals and TI-RADS scores were reassessed. The primary endpoint was the change in TI-RADS classification following RFA.</p><p><strong>Results: </strong>A total of 28 nodules from 25 patients were monitored after RFA for a median follow-up duration of 419 days. The majority (92.9%) were benign (Bethesda II) on FNA. The mean volume reduction ratio (VRR) was 66.7% (range 33.0% to 91.6%), with therapeutic success (VRR > 50%) achieved in 86% of patients. Post-RFA risk stratification increased following RFA, with the mean TI-RADS score increasing from 3.04 to 4.25 (p-value < 0.001), predominantly driven by increased hypo-echogenicity and new echogenic foci/calcifications.</p><p><strong>Conclusions: </strong>Thyroid nodules frequently undergo post RFA structural changes which result in misleading upstaging on the ACR TIRADS stratification system. These changes are expected and require cautious interpretation to avoid overdiagnosis, patient anxiety, and mismanagement.</p><p><strong>Abbreviations: </strong>RFA = radiofrequency ablation; ACR TI-RADS = American College of Radiology Thyroid Imaging Reporting & Data System; FNA = fine-needle aspiration; VRR = volume reduction ratio.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ACR TI-RADS Risk Score Escalation Observed in Benign Thyroid Nodules Following Radiofrequency Ablation.\",\"authors\":\"Tess J Battiola, Richard H Wiggins, Devaprabu Abraham\",\"doi\":\"10.3174/ajnr.A9028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>Radiofrequency ablation (RFA) has emerged as an effective non-surgical treatment for symptomatic benign thyroid nodules and toxic adenomas. While post-RFA ultrasonographic changes are expected, they may inadvertently evoke alarm and prompt unnecessary interventions when risk stratification models such as the American College of Radiology Thyroid Imaging Reporting & Data System (ACR TI-RADS) are applied. This study aims to quantify the ultrasound imaging changes using TIRADS scoring of thyroid nodules before and after RFA, and we highlight that these changes should not be used as a basis for clinical action.</p><p><strong>Materials and methods: </strong>This retrospective study analyzed patients who underwent RFA for symptomatic thyroid nodules at a quaternary care academic medical center between May 2021 and May 2024. All nodules were assessed using the ACR TI-RADS calculator and underwent fine-needle aspiration (FNA) biopsy prior to treatment. Following RFA, ultrasonography was conducted at 3-month intervals and TI-RADS scores were reassessed. The primary endpoint was the change in TI-RADS classification following RFA.</p><p><strong>Results: </strong>A total of 28 nodules from 25 patients were monitored after RFA for a median follow-up duration of 419 days. The majority (92.9%) were benign (Bethesda II) on FNA. The mean volume reduction ratio (VRR) was 66.7% (range 33.0% to 91.6%), with therapeutic success (VRR > 50%) achieved in 86% of patients. Post-RFA risk stratification increased following RFA, with the mean TI-RADS score increasing from 3.04 to 4.25 (p-value < 0.001), predominantly driven by increased hypo-echogenicity and new echogenic foci/calcifications.</p><p><strong>Conclusions: </strong>Thyroid nodules frequently undergo post RFA structural changes which result in misleading upstaging on the ACR TIRADS stratification system. These changes are expected and require cautious interpretation to avoid overdiagnosis, patient anxiety, and mismanagement.</p><p><strong>Abbreviations: </strong>RFA = radiofrequency ablation; ACR TI-RADS = American College of Radiology Thyroid Imaging Reporting & Data System; FNA = fine-needle aspiration; VRR = volume reduction ratio.</p>\",\"PeriodicalId\":93863,\"journal\":{\"name\":\"AJNR. American journal of neuroradiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AJNR. American journal of neuroradiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3174/ajnr.A9028\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A9028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:射频消融(RFA)已成为一种有效的非手术治疗症状性良性甲状腺结节和毒性腺瘤的方法。虽然rfa后的超声变化是意料之中的,但当应用风险分层模型(如美国放射学会甲状腺成像报告和数据系统(ACR TI-RADS))时,它们可能会在不经意间引起警报并促使不必要的干预。本研究旨在通过甲状腺结节的TIRADS评分量化RFA前后的超声成像变化,我们强调这些变化不应作为临床行动的依据。材料和方法:本回顾性研究分析了2021年5月至2024年5月在一家四级医疗学术医疗中心接受RFA治疗有症状甲状腺结节的患者。使用ACR TI-RADS计算器评估所有结节,并在治疗前进行细针穿刺(FNA)活检。RFA后,每隔3个月进行超声检查,并重新评估TI-RADS评分。主要终点是RFA后TI-RADS分类的变化。结果:RFA后共监测了25例患者的28个结节,中位随访时间为419天。绝大多数(92.9%)为良性(Bethesda II型)。平均体积缩小率(VRR)为66.7%(范围33.0% ~ 91.6%),86%的患者获得治疗成功率(VRR为50%)。RFA后风险分层增加,TI-RADS平均评分从3.04增加到4.25 (p值< 0.001),主要是低回声增强和新的回声灶/钙化所致。结论:甲状腺结节经常发生RFA后的结构改变,导致ACR TIRADS分层系统的误导。这些变化是预期的,需要谨慎解释,以避免过度诊断、患者焦虑和管理不善。缩写词:RFA =射频消融;美国放射学会甲状腺影像报告与数据系统;FNA =细针抽吸;VRR =体积缩小比。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ACR TI-RADS Risk Score Escalation Observed in Benign Thyroid Nodules Following Radiofrequency Ablation.

Background and purpose: Radiofrequency ablation (RFA) has emerged as an effective non-surgical treatment for symptomatic benign thyroid nodules and toxic adenomas. While post-RFA ultrasonographic changes are expected, they may inadvertently evoke alarm and prompt unnecessary interventions when risk stratification models such as the American College of Radiology Thyroid Imaging Reporting & Data System (ACR TI-RADS) are applied. This study aims to quantify the ultrasound imaging changes using TIRADS scoring of thyroid nodules before and after RFA, and we highlight that these changes should not be used as a basis for clinical action.

Materials and methods: This retrospective study analyzed patients who underwent RFA for symptomatic thyroid nodules at a quaternary care academic medical center between May 2021 and May 2024. All nodules were assessed using the ACR TI-RADS calculator and underwent fine-needle aspiration (FNA) biopsy prior to treatment. Following RFA, ultrasonography was conducted at 3-month intervals and TI-RADS scores were reassessed. The primary endpoint was the change in TI-RADS classification following RFA.

Results: A total of 28 nodules from 25 patients were monitored after RFA for a median follow-up duration of 419 days. The majority (92.9%) were benign (Bethesda II) on FNA. The mean volume reduction ratio (VRR) was 66.7% (range 33.0% to 91.6%), with therapeutic success (VRR > 50%) achieved in 86% of patients. Post-RFA risk stratification increased following RFA, with the mean TI-RADS score increasing from 3.04 to 4.25 (p-value < 0.001), predominantly driven by increased hypo-echogenicity and new echogenic foci/calcifications.

Conclusions: Thyroid nodules frequently undergo post RFA structural changes which result in misleading upstaging on the ACR TIRADS stratification system. These changes are expected and require cautious interpretation to avoid overdiagnosis, patient anxiety, and mismanagement.

Abbreviations: RFA = radiofrequency ablation; ACR TI-RADS = American College of Radiology Thyroid Imaging Reporting & Data System; FNA = fine-needle aspiration; VRR = volume reduction ratio.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信